论文信息 - Erlotinib in non-small cell lung cancer (NSCLC): Interim safety analysis of the TRUST study - 字舞流文

Erlotinib in non-small cell lung cancer (NSCLC): Interim safety analysis of the TRUST study

M. Krzakowski | U. Gatzemeier | A. Ardizzoni | F. Franke | O. Arrieta | M. Gottfried | P. Magyar | J. Meerbeeck | K. Horwood | N. V. Zandwijk